Core Insights - Profusa, Inc. is expanding its customer base in Europe through a collaboration with AZ Sint Blasius Hospital in Belgium, led by Dr. Koen Deloose, a recognized expert in critical limb ischemia [1][3] - Dr. Deloose's clinic employs a multidisciplinary approach to treat patients, integrating specialists in diabetic foot care, wound care, and podiatry [2] - Profusa's Lumee Oxygen monitoring system is expected to enhance treatment outcomes for patients with critical limb ischemia by providing real-time tissue oxygen metrics [2][3] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemical data [4] - The company aims to provide affordable, long-lasting biosensors that deliver actionable medical-grade data for both personal and clinical use [4] Leadership and Research - Dr. Koen Deloose has a significant background in vascular medicine, having authored over 200 articles in peer-reviewed journals and holding leadership roles in various medical organizations [2] - Profusa's CEO, Ben Hwang, emphasizes the alignment of Dr. Deloose's clinical work with the company's mission to improve health through accessible biochemical monitoring [3]